Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab

Bone marrow transplantation (BMT) was introduced as a treatment option 15 years ago for severe, drug-resistant multiple sclerosis (MS). Up until now, BMT has been undertaken in relatively few patients worldwide, with moderate success, and recent studies suggest that patients with early, highly aggre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mouzaki, Athanasia, Koutsokera, Maria, Dervilli, Zoe, Rodi, Maria, Kalavrizioti, Dimitra, Dimisianos, Nikolaos, Matsoukas, Ioannis, Papathanasopoulos, Panagiotis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2010
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2962327/
https://ncbi.nlm.nih.gov/pubmed/21042570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S13648
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak